Healthcare >> Analyst Interviews >> June 23, 2008

SMALL & MID-CAP BIOTECH COMPANIES – SIMOS SIMEONIDIS – BROADPOINT CAPITAL

TWST: Where are you concentrating your attention in biotech?

Dr. Simeonidis: I am looking at the public biotech space in a couple of

different ways. First of all, in terms of market cap size,